Traynor Capital Management’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-118
| Closed | -$1.44K | – | 290 |
|
|
2025
Q1 | $1.44K | Hold |
118
| – | – | ﹤0.01% | 237 |
|
|
2024
Q4 | $2.33K | Hold |
118
| – | – | ﹤0.01% | 253 |
|
|
2024
Q3 | $3.18K | Hold |
118
| – | – | ﹤0.01% | 247 |
|
|
2024
Q2 | $4.39K | Hold |
118
| – | – | ﹤0.01% | 241 |
|
|
2024
Q1 | $5.55K | Hold |
118
| – | – | ﹤0.01% | 241 |
|
|
2023
Q4 | $5.18K | Hold |
118
| – | – | ﹤0.01% | 222 |
|
|
2023
Q3 | $5.36K | Hold |
118
| – | – | ﹤0.01% | 203 |
|
|
2023
Q2 | $7.89K | Hold |
118
| – | – | ﹤0.01% | 201 |
|
|
2023
Q1 | $5.06K | Hold |
118
| – | – | ﹤0.01% | 196 |
|
|
2022
Q4 | $3.67K | Hold |
118
| – | – | ﹤0.01% | 200 |
|
|
2022
Q3 | $6K | Hold |
118
| – | – | ﹤0.01% | 180 |
|
|
2022
Q2 | $9K | Hold |
118
| – | – | ﹤0.01% | 175 |
|
|
2022
Q1 | $12K | Hold |
118
| – | – | ﹤0.01% | 199 |
|
|
2021
Q4 | $10K | Hold |
118
| – | – | ﹤0.01% | 221 |
|
|
2021
Q3 | $23K | Hold |
118
| – | – | ﹤0.01% | 197 |
|
|
2021
Q2 | $24K | Hold |
118
| – | – | ﹤0.01% | 184 |
|
|
2021
Q1 | $26K | Sell |
118
-30
| -20% | -$6.61K | ﹤0.01% | 180 |
|
|
2020
Q4 | $26K | Hold |
148
| – | – | ﹤0.01% | 157 |
|
|
2020
Q3 | $31K | Buy |
148
+30
| +25% | +$6.28K | 0.01% | 149 |
|
|
2020
Q2 | $29K | Hold |
118
| – | – | 0.01% | 150 |
|
|
2020
Q1 | $30K | Buy |
+118
| New | +$30K | 0.01% | 128 |
|
|
2016
Q3 | – | Hold |
0
| – | -$3K | – | 141 |
|
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 127 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 118 |
|